Akram R, Anwar H, Javed MS, Rasul A, Imran A, Malik SA, Raza C, Khan IU, Sajid F, Iman T, Sun T, Han HS, Hussain G (2022) Axonal regeneration: underlying molecular mechanisms and potential therapeutic targets. Biomedicines 10. https://doi.org/10.3390/biomedicines10123186.
Alotaibi A, Tench C, Stevenson R, Felmban G, Altokhis A, Aldhebaib A, Dineen RA, Constantinescu CS (2021) Investigating brain microstructural alterations in type 1 and type 2 diabetes using diffusion tensor imaging: a systematic review. Brain Sci 11:140. https://doi.org/10.3390/brainsci11020140
Article CAS PubMed PubMed Central Google Scholar
Callisaya ML, Beare R, Moran C, Phan T, Wang W, Srikanth VK (2019) Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study. Diabetologia 62:448–458. https://doi.org/10.1007/s00125-018-4778-9
Dhaliwal J, Dhaliwal N, Akhtar A, Kuhad A, Chopra K (2022) Tetramethylpyrazine attenuates cognitive impairment via suppressing oxidative stress, neuroinflammation, and apoptosis in type 2 Diabetic rats. Neurochem Res 47:2431–2444. https://doi.org/10.1007/s11064-022-03640-x
Article CAS PubMed Google Scholar
Gao S, Chen Y, Sang F, Yang Y, Xia J, Li X, Zhang J, Chen K, Zhang Z (2019) White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes. Diabetes 68:2085–2094. https://doi.org/10.2337/db19-0233
Article CAS PubMed PubMed Central Google Scholar
Grosu S, Lorbeer R, Hartmann F, Rospleszcz S, Bamberg F, Schlett CL, Galie F, Selder S, Auweter S, Heier M, Rathmann W, Mueller-Peltzer K, Ladwig KH, Peters A, Ertl-Wagner BB, Stoecklein S (2021) White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia. BMJ Open Diabetes Res Care 9. https://doi.org/10.1136/bmjdrc-2020-002050
Habtemariam S (2020) Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res 155:104722. https://doi.org/10.1016/j.phrs.2020.104722
Article CAS PubMed Google Scholar
Hu X, Zhang Y, Xue Y, Zhang Z, Wang J (2018) Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation. Am J Transl Res 10:3322–3329
CAS PubMed PubMed Central Google Scholar
Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142:387–397. https://doi.org/10.1016/j.cell.2010.06.036
Article CAS PubMed Google Scholar
Jing J, Zhou Y, Pan Y, Cai X, Zhu W, Zhang Z, Li Z, Liu C, Meng X, Cheng J, Wang Y, Li H, Wu Z, Wang S, Niu H, Wen W, Liu T, Wei T, Wang Y, Sachdev PS (2022) Reduced white matter microstructural integrity in prediabetes and diabetes: a population-based study. EBioMedicine 82:104144. https://doi.org/10.1016/j.ebiom.2022.104144
Article CAS PubMed PubMed Central Google Scholar
King MR, Anderson NJ, Guernsey LS, Jolivalt CG (2013) Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. J Neurosci Res 91:506–514. https://doi.org/10.1002/jnr.23192
Article CAS PubMed PubMed Central Google Scholar
Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T (2002) Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113:607–615. https://doi.org/10.1016/s0306-4522(02)00162-8
Article CAS PubMed Google Scholar
Li HY, Wang XC, Xu YM, Luo NC, Luo S, Hao XY, Cheng SY, Fang JS, Wang Q, Zhang SJ, Chen YB (2018) Berberine improves diabetic encephalopathy through the SIRT1/ER stress pathway in db/db mice. Rejuvenation Res 21:200–209. https://doi.org/10.1089/rej.2017.1972
Article CAS PubMed Google Scholar
Liang Y, Xu X, Yin M, Zhang Y, Huang L, Chen R, Ni J (2019) Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocr J 66:51–63. https://doi.org/10.1507/endocrj.EJ18-0109
Article CAS PubMed Google Scholar
Liu J, Liu T, Wang W, Ma L, Ma X, Shi S, Gong Q, Wang M (2017) Reduced gray matter volume in patients with type 2 diabetes mellitus. Front Aging Neurosci 9:161. https://doi.org/10.3389/fnagi.2017.00161
Article CAS PubMed PubMed Central Google Scholar
Ma T, Li ZY, Yu Y, Hu B, Han Y, Ni MH, Huang YX, Chen HH, Wang W, Yan LF, Cui GB (2022) Gray and white matter abnormality in patients with T2DM-related cognitive dysfunction: a systemic review and meta-analysis. Nutr Diabetes 12:39. https://doi.org/10.1038/s41387-022-00214-2
Article PubMed PubMed Central Google Scholar
Peltier J, Roussel M, Gerard Y, Lassonde M, Deramond H, Le Gars D, De Beaumont L, Godefroy O (2012) Functional consequences of a section of the anterior part of the body of the corpus callosum: evidence from an interhemispheric transcallosal approach. J Neurol 259:1860–1867. https://doi.org/10.1007/s00415-012-6421-x
Pu K, Wu M, Jiang T, Zhang Y, Ye M, Sun J, Ma H, Zhai Q, Wang Q (2022) Involvement of paired immunoglobulin-like receptor B in diabetes-associated cognitive dysfunction through modulation of axon outgrowth and dendritic remodeling. Mol Neurobiol 59:2563–2579. https://doi.org/10.1007/s12035-021-02679-1
Article CAS PubMed Google Scholar
Qiu Q, Lei X, Wang Y, Xiong H, Xu Y, Sun H, Xu H, Zhang N (2023) Naringin protects against tau hyperphosphorylation in abeta (25–35)-Injured PC12 cells through modulation of ER, PI3K/AKT, and GSK-3beta signaling pathways. Behav Neurol 2023:1857330. https://doi.org/10.1155/2023/1857330
Ramos-Rodriguez JJ, Ortiz O, Jimenez-Palomares M, Kay KR, Berrocoso E, Murillo-Carretero MI, Perdomo G, Spires-Jones T, Cozar-Castellano I, Lechuga-Sancho AM, Garcia-Alloza M (2013) Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology 38:2462–2475. https://doi.org/10.1016/j.psyneuen.2013.05.010
Roland JL, Snyder AZ, Hacker CD, Mitra A, Shimony JS, Limbrick DD, Raichle ME, Smyth MD, Leuthardt EC (2017) On the role of the corpus callosum in interhemispheric functional connectivity in humans. Proc Natl Acad Sci U S A 114:13278–13283. https://doi.org/10.1073/pnas.1707050114
Article CAS PubMed PubMed Central Google Scholar
Sandrone S, Aiello M, Cavaliere C, Thiebaut de Schotten M, Reimann K, Troakes C, Bodi I, Lacerda L, Monti S, Murphy D, Geyer S, Catani M, Dell’Acqua F (2023) Mapping myelin in white matter with T1-weighted/T2-weighted maps: discrepancy with histology and other myelin MRI measures. Brain Struct Funct 228:525–535. https://doi.org/10.1007/s00429-022-02600-z
Article PubMed PubMed Central Google Scholar
Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ (2020) Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol 8:535–545. https://doi.org/10.1016/S2213-8587(20)30118-2
Takahashi-Yanaga F (2013) Activator or inhibitor? GSK-3 as a new drug target. Biochem Pharmacol 86:191–199. https://doi.org/10.1016/j.bcp.2013.04.022
Article CAS PubMed Google Scholar
Tian L, Ri H, Qi J, Fu P (2021) Berberine elevates mitochondrial membrane potential and decreases reactive oxygen species by inhibiting the Rho/ROCK pathway in rats with diabetic encephalopathy. Mol Pain 17:1744806921996101. https://doi.org/10.1177/1744806921996101
Article CAS PubMed PubMed Central Google Scholar
Udagawa J, Hashimoto R, Suzuki H, Hatta T, Sotomaru Y, Hioki K, Kagohashi Y, Nomura T, Minami Y, Otani H (2006) The role of leptin in the development of the cerebral cortex in mouse embryos. Endocrinology 147:647–658. https://doi.org/10.1210/en.2005-0791
Article CAS PubMed Google Scholar
Wang X, Zhao L (2016) Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway. Biochem Biophys Res Commun 473:428–434. https://doi.org/10.1016/j.bbrc.2016.03.024
Article CAS PubMed Google Scholar
Wang Z, Huang Y, Cheng Y, Tan Y, Wu F, Wu J, Shi H, Zhang H, Yu X, Gao H, Lin L, Cai J, Zhang J, Li X, Cai L, Xiao J (2016) Endoplasmic reticulum stress-induced neuronal inflammatory response and apoptosis likely plays a key role in the development of diabetic encephalopathy. Oncotarget 7:78455–78472. https://doi.org/10.18632/oncotarget.12925
Comments (0)